Skip to main content

Table 1 Maternal characteristics at baseline (n = 23)

From: Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

  

Intervention (Glibenclamide)(n = 13)

Standard (Insulin) (n = 10)

Total (n = 23)

Maternal age (years)

Mean (SD)

33.0 (5.1)

34.5 (4.9)

33.7 (5.0)

BMI (kg/m2) at randomisation

  < 40

n (%)

8 (61.5)

8 (80.0)

16 (69.6)

  ≥ 40

n (%)

5 (38.5)

2 (20.0)

7 (30.4)

Median [IQR]

39.2 [33.2 to 40.6]

33.3 [29.5 to 38.2]

35.7 [32.0 to 40.5]

Gestational age at randomisation (weeks)

Mean (SD)

29.6 (6.3)

31.5 (2.2)

30.4 (4.9)

Gestation at diagnosis of gestational diabetes (weeks)

Median [IQR]

24.9 [17.6 to 28.9]

27.1[24.0 to 28.9]

26.7[17.6 to 28.9]

Daily dose of metformin at randomisation (mg)

Median [IQR]

1500 [1500 to 2000]

1500 [1500 to 2000]

1500 [1500 to 2000]

Ethnicity

 White

n (%)

10

(76.9)

7

(70.0)

17

(73.9)

 Indian

n (%)

0

(0.0)

2

(20.0)

2

(8.7)

 Pakistani

n (%)

1

(7.7)

1

(10.0)

2

(8.7)

 Bangladeshi

n (%)

0

(0.0)

0

(0.0)

0

(0.0)

 Other Asian background

n (%)

1

(7.7)

0

(0.0)

1

(4.4)

 Black

n (%)

1

(7.7)

0

(0.0)

1

(4.4)

Deprivation levela

 1 (Most deprived)

n (%)

6

(46.2)

4

(40.0)

10

(43.5)

 2

n (%)

3

(23.1)

2

(20.0)

5

(21.7)

 3

n (%)

1

(7.7)

0

(0.0)

1

(4.3)

 4

n (%)

2

(15.4)

1

(10.0)

3

(13.0)

 5 (Least deprived)

n (%)

1

(7.7)

3

(30.0)

4

(17.4)

Number of previous pregnanciesb

 0

n (%)

1

(7.7)

2

(22.2)

3

(13.6)

 1 or more

n (%)

12

(92.3)

7

(77.8)

19

(86.4)

Blood pressure (mmHg)

 Systolic

Mean (SD)

118.4

(11.4)

122.2

(10.8)

120.0

(11.0)

 Diastolic

Mean (SD)

72.2

(7.0)

72.6

(8.7)

72.3

(7.6)

  1. a From the Scottish Index of Multiple Deprivation http://www.isdscotland.org/Products-and-Services/GPD-Support/Deprivation/SIMD/index.asp?Co=Y
  2. b All lengths, including miscarriages; data missing from 1 participant in the insulin-treatment group